The 'Newsom Veto' Aftermath: What’s Left for MedTech AI Safety?
SB 1047 is dead, but these 18 other AI bills are very much alive. Don't get distracted. 🛡️
The Focus Shifts
When Governor Newsom vetoed SB 1047 (the controversial "kill switch" bill), many in the tech industry breathed a sigh of relief. However, for MedTech, the regulatory landscape actually became more complex.
The veto signaled a shift away from broad, existential risk regulation toward targeted, sector-specific rules. The legislature passed, and the Governor signed, a raft of bills that directly impact healthcare AI.
Key Bills to Watch
- AB 3030: Requires disclosure when patients interact with Generative AI. This affects chatbots, virtual nurses, and automated scheduling tools.
- AB 2013: Mandates transparency regarding the data used to train Generative AI models. This impacts any MedTech company building its own foundation models.
- SB 1120: Requires physician oversight for AI-driven utilization review decisions, effectively banning "auto-denials" by algorithms.
- AB 489: Prohibits AI from misrepresenting itself as a licensed medical professional.
The "Patchwork" Problem
Instead of one omnibus law to comply with, MedTech companies now face a patchwork of requirements. You need a compliance strategy that addresses each of these bills individually.
Conclusion
The death of SB 1047 was not a "get out of jail free" card. It was a pivot. The state is now regulating AI based on how it is used, and healthcare is a primary target. Compliance is not optional; it's a condition of operating in California.
Frequently Asked Questions (FAQ)
Will SB 1047 come back?
Likely yes, in a different form. State Senator Wiener has indicated he will reintroduce safety legislation. However, it may be more tailored or address the Governor's concerns about stifling open-source innovation.
Do these laws apply to FDA-approved devices?
This is a complex legal area involving "preemption." Generally, states can regulate consumer protection and professional licensing (like the practice of medicine) even if a device is FDA cleared. It is risky to assume FDA approval shields you from state transparency laws.
When do these new laws take effect?
Most of the bills signed in the last session take effect on January 1, 2025, or January 1, 2026. You should check the specific effective date for each bill relevant to your product.